MAPT and Parkinson disease: Herein, α-syn was demonstrated to interact with Aβ1–42 and tau in RBCs of PD patients; in particular, α-syn-Aβ1–42 concentrations were elevated in PD subjects and directly correlated with disease severity and motor deficits in patients under therapy.